Description: Figure 26 shows pooled results indicating a slight, but not significant, increase in the risk of breast cancer among BRCA carriers who have ever used OCs, with an odds ratio of 1.21 (95% CI, 0.93 to 1.58).

Figure 26Forest plot for BRCA carriers compared with each other (breast cancer incidence)

CI = confidence interval; OC = oral contraceptive

From: 3, Oral Contraceptives and Other Cancers

Cover of Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer.
Evidence Reports/Technology Assessments, No. 212.
Havrilesky LJ, Gierisch JM, Moorman PG, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.